1. Home
  2. INVE vs CTMX Comparison

INVE vs CTMX Comparison

Compare INVE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • CTMX
  • Stock Information
  • Founded
  • INVE 1990
  • CTMX 2008
  • Country
  • INVE United States
  • CTMX United States
  • Employees
  • INVE N/A
  • CTMX N/A
  • Industry
  • INVE Computer peripheral equipment
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • CTMX Health Care
  • Exchange
  • INVE Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • INVE 86.5M
  • CTMX 85.3M
  • IPO Year
  • INVE 1997
  • CTMX 2015
  • Fundamental
  • Price
  • INVE $3.59
  • CTMX $0.96
  • Analyst Decision
  • INVE Strong Buy
  • CTMX Buy
  • Analyst Count
  • INVE 2
  • CTMX 6
  • Target Price
  • INVE $7.25
  • CTMX $5.77
  • AVG Volume (30 Days)
  • INVE 39.3K
  • CTMX 963.1K
  • Earning Date
  • INVE 03-11-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • INVE N/A
  • CTMX N/A
  • EPS Growth
  • INVE N/A
  • CTMX N/A
  • EPS
  • INVE 3.10
  • CTMX 0.16
  • Revenue
  • INVE $104,217,000.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • INVE N/A
  • CTMX $22.55
  • Revenue Next Year
  • INVE N/A
  • CTMX N/A
  • P/E Ratio
  • INVE $1.15
  • CTMX $5.81
  • Revenue Growth
  • INVE 70.57
  • CTMX 33.66
  • 52 Week Low
  • INVE $2.95
  • CTMX $0.79
  • 52 Week High
  • INVE $9.24
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • INVE 45.04
  • CTMX 49.88
  • Support Level
  • INVE $3.50
  • CTMX $0.82
  • Resistance Level
  • INVE $3.82
  • CTMX $0.96
  • Average True Range (ATR)
  • INVE 0.18
  • CTMX 0.06
  • MACD
  • INVE -0.01
  • CTMX 0.01
  • Stochastic Oscillator
  • INVE 29.09
  • CTMX 71.92

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: